As per MRFR analysis, the Ophthalmic Viscoelastic Devices Market Size was estimated at 2.04 (USD Billion) in 2023. The Ophthalmic Viscoelastic Devices Market is expected to grow from 2.13 (USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 4.62% during the forecast period (2025 - 2035).
The Ophthalmic Viscoelastic Devices Market is experiencing notable trends driven by the increasing prevalence of eye diseases and the growing aging population, which creates higher demand for surgical procedures. The rise in cataract surgeries and other ophthalmic surgeries is contributing significantly to the market's growth. Furthermore, advancements in technology have led to the development of innovative viscoelastic devices that improve surgical outcomes, making procedures safer and more efficient.
This reflects a key market driver as healthcare professionals increasingly adopt these advanced products to enhance patient care. Opportunities in this market can be explored through the introduction of new, cost-effective product variations that meet the diverse needs of different healthcare providers globally.
Since many areas are working to improve their healthcare infrastructure, there is a lot of room for businesses to add new products and reach new markets. For example, areas where healthcare spending is going up may be good places to launch new devices that are made for certain types of surgery. Recent trends show that a lot of attention is being paid to research and development efforts to make viscoelastic formulations that work better during eye surgeries. Manufacturers are paying attention to the need for sustained-release formulations and biocompatible materials, which has led to new products.
Additionally, an increasing number of partnerships and collaborations among industry participants are observed, aimed at enhancing distribution networks and achieving better market penetration. These trends collectively shape the competitive landscape of the Ophthalmic Viscoelastic Devices Market, suggesting ongoing evolution and adaptation in response to the healthcare needs of patients worldwide.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Ophthalmic Viscoelastic Devices Market is heavily driven by the rising prevalence of eye disorders such as cataracts and glaucoma. According to the World Health Organization, the number of individuals affected by cataracts is anticipated to reach approximately 32 million by 2025, a significant rise from 24 million in 2010. The increase in the aging population globally is a major contributing factor, as age-related diseases are on the rise.
Key organizations like the American Academy of Ophthalmology continuously report the growing need for surgical procedures related to these conditions. The demand for effective ophthalmic viscoelastic devices, which are crucial in cataract surgeries, is expected to substantially increase as these numbers represent a vast patient population requiring intervention. This trend will further strengthen the growth of the Ophthalmic Viscoelastic Devices Market.
Technological innovations in surgical procedures, particularly minimally invasive techniques, are propelling the Ophthalmic Viscoelastic Devices Market. Developments in equipment and surgical methods significantly enhance the performance of ophthalmic viscoelastic devices, increasing their effectiveness in various ophthalmic surgeries. Organizations such as the European Society of Cataract and Refractive Surgeons are actively promoting advanced surgical techniques, which have been shown to improve patient outcomes.
Reports indicate that the introduction of newer viscoelastic devices with enhanced properties, such as better flow characteristics, has led to improved surgical efficiency and outcomes. This wave of progress in ophthalmic technology urges healthcare providers to adopt cutting-edge solutions, fostering growth in the market.
The escalating global healthcare expenditure is acting as a significant driver for the Ophthalmic Viscoelastic Devices Market. An increase in budgets allocated for healthcare services enables healthcare facilities to invest in advanced surgical tools, including ophthalmic viscoelastic devices. Data from the World Bank indicates that global health spending has seen an increase of over 30% in the past decade, reaching upwards of 10 trillion USD.
This investment trend is evident in countries that emphasize improving healthcare access and quality, such as those in the Global North. As hospitals and clinics are better equipped financially, demand for new and effective ophthalmic products for surgical applications, including viscoelastic devices, is anticipated to rise.
The rapid growth of the geriatric population globally is a crucial driver in shaping the Ophthalmic Viscoelastic Devices Market. The United Nations reports that by 2050, the number of individuals aged 60 years and older will reach approximately 2.1 billion, effectively doubling from the 2017 figures. This demographic shift leads to an increase in age-related eye conditions that require surgical intervention. Organizations such as the International Council on Aging are focusing on this demographic, highlighting the demand for eye care services.
Increased visibility of age-related conditions necessitates improved surgical techniques, resulting in higher usage of ophthalmic viscoelastic devices. Thus, the aging population will significantly support the expanded growth of the Ophthalmic Viscoelastic Devices Market.
The Application segment of the Ophthalmic Viscoelastic Devices Market is integral to understanding the dynamics of this industry, as it encompasses crucial procedures like Cataract Surgery, Corneal Surgery, Glaucoma Surgery, and Refractive Surgery. In 2024, the market is projected to experience significant activity, with the Cataract Surgery sector notably valued at 0.9 USD Billion, a figure that is expected to grow to 1.5 USD billion by 2035, reflecting the increasing prevalence of cataracts and a growing aging population. Conversely, the Corneal Surgery category is valued at 0.25 USD billion in 2024, anticipating a growth to 0.4 USD billion in 2035, highlighting its emerging importance in the treatment of various corneal diseases.
Glaucoma Surgery, projected at 0.33 USD Billion in 2024, is set to rise to 0.55 USD Billion by 2035, indicating a growing recognition of the need for effective treatment options in managing glaucoma, a leading cause of irreversible blindness globally. Refractive Surgery is also a significant contributor to the market, with a value of 0.65 USD billion in 2024, expected to reach 1.0 USD Billion in 2035, as more patients seek corrective surgery for vision impairment. The significant projected values and growth of these applications underscore their dominance and the essential role they play in enhancing patient care and surgical outcomes.
An increase in awareness and technological advancements, coupled with an uptick in the aging global population, drives growth in the Ophthalmic Viscoelastic Devices Market. Each application not only holds a significant share in the overall revenue but also reflects broader trends in ophthalmic healthcare, where the demand for effective and safe surgical solutions is critical. This segmentation provides insights into market trends, challenges, and opportunities, enabling stakeholders to identify and capitalize on emerging healthcare needs and innovations.
As the Ophthalmic Viscoelastic Devices Market evolves, these applications are set to remain at the forefront of advancements in ophthalmic surgery, ensuring they continue to play a pivotal role in improving clinical outcomes and enhancing patient quality of life.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Ophthalmic Viscoelastic Devices Market comprises various product types, including Hydrophobic, Hydrophilic, and Combination categories, which play pivotal roles in ophthalmic surgical procedures. The market is expected to achieve a revenue of 2.13 billion USD by 2024, growing significantly as advancements continue in technology and surgical techniques. Hydrophobic viscoelastic devices are known for their cohesive properties, aiding in the maintenance of anterior chamber stability during surgeries, thus being favored in procedures like cataract surgeries.
Hydrophilic devices, on the other hand, are appreciated for their excellent capability to maintain hydration, offering easier application and removal, making them important in surgical applications. The Combination products serve as a versatile option by integrating the advantages of both hydrophobic and hydrophilic materials, appealing to a wide range of surgical needs. The growth is driven by the increasing prevalence of eye disorders, advancements in surgical procedures, and rising awareness surrounding eye health. However, challenges such as regulatory hurdles and the requirement for skilled professionals may impact market dynamics.
Overall, the Ophthalmic Viscoelastic Devices Market segmentation showcases diverse product types catering to the increasing demand for efficient ophthalmic surgeries.
The Ophthalmic Viscoelastic Devices Market is poised for significant growth, particularly within the End User segment, projected to be valued at 2.13 USD Billion in 2024 and evolving further as the market grows. Hospitals play a crucial role, acting as the primary setting for various ophthalmic procedures, thus supporting a steady demand for viscoelastic devices. Ambulatory Surgical Centers have gained prominence due to their ability to offer cost-effective surgical solutions and shorter patient recovery times, making them increasingly popular among patients and healthcare providers alike.
Ophthalmic Clinics, which specialize in eye care, are expected to continue driving innovation and adoption of advanced viscoelastic products, enhancing surgical outcomes. Overall, the Ophthalmic Viscoelastic Devices Market segmentation highlights the importance of these End Users, as they contribute significantly to market growth through their ability to provide specialized services and improved patient care, showcasing the dynamic nature of the industry. As the market progresses toward 2035, advancements in technology and increasing patient awareness about ophthalmic health will likely further propel this segment's development.
The Ophthalmic Viscoelastic Devices Market, with a projected revenue reaching 2.13 USD Billion in 2024, showcases noteworthy segmentation through Formulation Type, distinguishing between Single-Use and Multi-Use categories. The rising preference for Single-Use devices is propelled by increased concerns regarding infection control and the need for enhanced patient safety during ophthalmic procedures. This formulation type not only reduces the risk of cross-contamination but also aligns with the industry’s growing trend toward disposable healthcare products.
Conversely, Multi-Use formulations maintain a significant presence, appealing to cost-sensitive segments where budget constraints govern purchasing decisions. The versatility of Multi-Use products holds importance in ophthalmic surgeries, as they offer more extensive application over time, balancing performance with economic feasibility. As a result, the Ophthalmic Viscoelastic Devices Market data indicates a strategic shift towards Single-Use devices, which is anticipated to be a driving force in market growth and evolution through 2035, in alignment with broader healthcare trends prioritizing efficiency and safety.
Market challenges persist in ensuring regulatory compliance and managing product variability in Multi-Use offerings, but these segments collectively underscore the evolving dynamics of the industry.
The Ophthalmic Viscoelastic Devices Market showcases distinct regional dynamics, with North America holding a majority share valued at 0.82 USD billion in 2024, projected to reach 1.32 USD billion by 2035. This dominance is attributed to advanced healthcare infrastructure and high demand for ophthalmic procedures. Europe follows, valued at 0.62 USD billion in 2024 and expected to grow to 1.01 USD billion by 2035, benefiting from an aging population and increased awareness of eye health. In South America, the market starts at 0.15 USD billion in 2024, growing modestly to 0.25 USD billion by 2035, indicating emerging opportunities in this developing region.
Asia Pacific, valued at 0.38 USD billion in 2024, will see growth to 0.61 USD billion by 2035, driven by rising disposable incomes and increasing eye surgeries. The Middle East and Africa hold a smaller share at 0.16 USD billion in 2024, expanding to 0.26 USD billion by 2035, due to limited access to advanced healthcare technologies. Overall, the segmentation reflects significant opportunities shaped by regional healthcare advancements and demographic trends within the Ophthalmic Viscoelastic Devices Market.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Ophthalmic Viscoelastic Devices Market has been experiencing significant growth, driven by advancements in medical technology and an increasing demand for eye surgeries. These devices play a crucial role in various ophthalmic procedures, offering benefits such as improved surgical visibility, reduced trauma during surgery, and enhanced recovery for patients. Key players in this market are continuously innovating their product lines and seeking new opportunities through strategic partnerships and collaborations.
The competition in this sector is characterized by a mix of established companies that have a robust portfolio of viscoelastic products as well as emerging firms that are looking to carve out a niche by focusing on specific segments within the ophthalmic landscape. As the demand for eye-related surgeries rises due to an aging population and the prevalence of eye diseases, the competitive landscape is expected to intensify, with companies vying to secure their market share through innovative solutions and effective marketing strategies.
Ocular Therapeutix has made a notable impact within the Ophthalmic Viscoelastic Devices Market by leveraging its unique technologies and proprietary formulations. The company is primarily known for developing products that target patients undergoing ocular surgeries, particularly in relation to cataracts and other eye conditions. Ocular Therapeutix possesses particular strengths in its research and development capabilities, enabling it to create advanced viscoelastic devices that enhance patient experiences during and after surgical procedures.
The company has established a solid presence in the global market through strategic collaborations with healthcare providers and eye care professionals, thereby positioning itself as a key player in the ophthalmic sector. Additionally, Ocular Therapeutix's focus on innovation allows it to stay ahead of competitors and respond effectively to emerging trends in the market, thus reinforcing its competitive advantages.
Rayner Intraocular Lenses operates within the Ophthalmic Viscoelastic Devices Market with a strong emphasis on the development and distribution of advanced intraocular lenses and associated viscoelastic products. Renowned for its innovative eye care solutions, Rayner has built a reputation for high-quality devices that cater to the needs of both healthcare professionals and patients. The company focuses on delivering cutting-edge products that improve surgical outcomes and patient satisfaction. Its key offerings include a wide range of intraocular lenses, used for a variety of surgical applications, alongside proprietary viscoelastic agents.
Rayner's strengths lie in its strong market presence and extensive distribution network, which support its ability to reach global markets effectively. Furthermore, the company is known for its strategic mergers and acquisitions that have broadened its product lines and enhanced its technological capabilities. Such initiatives have allowed Rayner to refine its offerings and solidify its position as a leading entity in the Ophthalmic Viscoelastic Devices Market.
The Ophthalmic Viscoelastic Devices Market is still growing quickly as of July 2025. This is because cataract surgery technologies are getting better, and more people around the world are getting age-related eye problems. Alcon said in July 2023 that its second quarter was very good. It said that part of the reason for its success was that there was still a lot of demand for its surgical products, like viscoelastic products like Viscoat and ProVisc, which are commonly used in cataract surgery. Bausch + Lomb (part of Bausch Health Companies) and Johnson & Johnson Vision have also seen good market momentum over the past year.
This is because more money is being spent on eye research and development, and more procedures are being done around the world. These companies have well-known OVD product lines, like the Healon series and OcuCoat. In August 2022, Hoya Corporation made news by putting money into its medical division, but it didn't say which viscoelastic devices it bought or how much it raised its stake in them. In the same way, Carl Zeiss AG has been growing its presence in the field of ophthalmic surgery, but there is no confirmed acquisition of viscoelastic technologies in January 2023. It's important to remember that companies like Ocular Therapeutix, which makes drug-eluting inserts like Dextenza, are not involved in the OVD segment.
Their main focus is still on long-term drug delivery for eye conditions, not surgical viscoelastic formulations. Overall, the OVD market is growing because of new ideas, more procedures being done, and a global push for more advanced, patient-centered surgical technologies. The focus on cohesive and dispersive formulations that are tailored to the surgeon's preferences and the type of procedure continues to shape the development and use of products in both developed and emerging markets.
| Report Attribute/Metric | Details |
| Market Size 2023 | 2.04 (USD Billion) |
| Market Size 2024 | 2.13 (USD Billion) |
| Market Size 2035 | 3.5 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 4.62% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Ocular Therapeutix, Rayner Intraocular Lenses, Carl Zeiss AG, Alcon, Hoya Corporation, Genzyme, Janssen Pharmaceuticals, Bausch Health, Johnson & Johnson, Santen Pharmaceutical, Abbott Laboratories |
| Segments Covered | Application, Product Type, End User, Formulation Type, Regional |
| Key Market Opportunities | Increasing cataract surgeries, Rising demand for premium IOLs, Advancements in viscoelastic formulations, Growth in minimally invasive surgeries, Expanding applications in glaucoma treatments |
| Key Market Dynamics | Growing cataract surgeries, increasing aging population, technological advancements in devices, rising demand for eye surgeries, expanding healthcare expenditure |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Ophthalmic Viscoelastic devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Ophthalmic Viscoelastic Devices Market is expected to be valued at 2.13 USD billion in 2024.
By 2035, the Ophthalmic Viscoelastic Devices Market is projected to reach a value of 3.5 USD billion.
The expected CAGR for the Ophthalmic Viscoelastic Devices Market from 2025 to 2035 is 4.62%.
North America is projected to hold the largest market share, valued at 0.82 USD billion in 2024.
The market value for Cataract Surgery applications is expected to reach 1.5 USD billion by 2035.
The market size for the Asia Pacific region is expected to be 0.38 USD billion in 2024.
Major players include Ocular Therapeutix, Alcon, and Johnson & Johnson, among others.
The market size for Glaucoma Surgery applications is projected to reach 0.55 USD billion by 2035.
The market for Corneal Surgery applications is anticipated to be valued at 0.4 USD Billion in 2035.
Challenges may include regulatory hurdles and competition among key players in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
